Q301 Histocompatibility Transplant Testing and Interpretation

SOL #: 36C26026Q0245_1Combined Synopsis/Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
260-NETWORK CONTRACT OFFICE 20 (36C260)
VANCOUVER, WA, 98661, United States

Place of Performance

Portland, OR

NAICS

Medical Laboratories (621511)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 4, 2026
2
Submission Deadline
Feb 28, 2026, 1:00 AM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the VA Portland Health Care System (VAPORHCS), has issued a Combined Synopsis/Solicitation for Histocompatibility and Immunogenetics Testing and Interpretation Reference Laboratory Services. This is an unrestricted acquisition for a Firm-Fixed Price Indefinite Delivery Indefinite Quantity (IDIQ) contract. The services are crucial to support the VAPORHCS transplant program, as the facility lacks in-house capabilities and OPTN accreditation for these specialized tests. Proposals are due by February 27, 2026, at 5:00 PM Pacific Time.

Scope of Work

The contractor will provide comprehensive histocompatibility and immunogenetics testing, reporting, and interpretation services. Key responsibilities include:

  • Performing patient specimen testing, pre-analytical processing, analysis, and reporting.
  • Providing necessary supplies (requisition forms, specimen containers, collection kits) and managing shipping to and from patients/VA facilities.
  • Maintaining active membership and compliance with Organ Procurement and Transplantation Network (OPTN) requirements.
  • Demonstrating affiliation with the federally designated OPO of Oregon (Cascade Life Alliance) and the Portland VA Transplant Program.
  • Providing robust 24/7 on-call services for critical donor testing.
  • Performing various non-testing tasks related to transplant patient management, such as OPTN kidney waitlist registration, management of hard-to-transplant candidates, crossmatch protocols, antibody screening, and coordination with OPOs.
  • Complying with all applicable federal, state, and local regulations, including HIPAA for electronic transmission of results.

Contract Details & Timeline

  • Contract Type: Firm-Fixed Price IDIQ
  • Period of Performance: Five Ordering Periods, from April 1, 2026, to March 31, 2031 (one base year and four one-year options).
  • Total Capacity: $9,000,000.00 over the entire PoP.
  • Minimum Guarantee: $1,000.00
  • Set-Aside: Unrestricted (Not set aside for small business concerns).
  • NAICS Code: 621511 (Size Standard: $41.5 Million)
  • Product/Service Code: Q301 (Reference Laboratory Testing)
  • Published Date: February 4, 2026
  • Response Due: February 27, 2026, at 5:00 PM Pacific Time (Los Angeles, USA).

Performance Standards & Requirements

  • Accreditation: Laboratory must be accredited by OPTN and meet ASHI or CAP standards.
  • Personnel: All personnel must meet CLIA '88 qualifications and possess current professional certifications; subject to low-risk background investigations.
  • Turnaround Times (TAT): STAT testing for deceased donors must begin within one hour of sample arrival/verbal request, with results reported within 6 hours. Routine test results must meet specified TATs.
  • Quality: Maintain a minimum of 95% success rate for proficiency testing; 100% compliance with quality of work and security requirements.
  • Security: Adherence to strict security requirements, including data protection, encryption, and incident reporting.
  • Customer Service: Provide 24/7 customer service and access to medical/technical directors for consultation.
  • Pricing: Bidders must complete Attachment B (Test List Histocompatibility) and B.2 (Price/Cost Schedule), detailing pricing for various tests across the five ordering periods.

Evaluation Factors

Award will be based on a combination of:

  • Technical Performance (80%): Evaluated based on factors outlined in Attachment C, including testing capabilities, licensures, certifications, personnel qualifications, TATs, accreditations (OPTN, CAP/ASHI), OPO/Transplant Service affiliations, non-testing task agreement, on-call system, and courier services.
  • Past Performance (10%)
  • Price (10%)

Contact Information

For questions, contact Eric A Lingenfelter at Eric.Lingenfelter@va.gov or 360-852-9891.

People

Points of Contact

Eric A LingenfelterPRIMARY

Files

Files

Download
Download
Download
Download

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Feb 4, 2026
Q301 Histocompatibility Transplant Testing and Interpretation | GovScope